Taysha Gene Therapies Inc’s filing revealed that its Officer Rumana Haque-Ahmed acquired Company’s shares for reported $30479.0 on Sep 22 ’25. In the deal valued at $2.83 per share,10,770 shares were bought.
Then, Nagendran Sukumar sold 200,000 shares, generating $646,000 in total proceeds. Upon selling the shares at $3.23, the President and Head of R&D now owns 1,006,439 shares.
Before that, Nagendran Sukumar bought 200,000 shares. Taysha Gene Therapies Inc shares valued at $652,000 were divested by the Officer at a price of $3.26 per share.
Raymond James initiated its Taysha Gene Therapies Inc [TSHA] rating to a Strong buy in a research note published on October 21, 2025; the price target was $13. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. BMO Capital Markets began covering TSHA with “an Outperform” recommendation on June 27, 2024. Piper Sandler started covering the stock on April 09, 2024. It rated TSHA as “an Overweight”.
Price Performance Review of TSHA
On Tuesday, Taysha Gene Therapies Inc [NASDAQ:TSHA] saw its stock jump 2.25% to $4.99. Over the last five days, the stock has lost -3.11%. Taysha Gene Therapies Inc shares have risen nearly 153.30% since the year began. Nevertheless, the stocks have risen 188.44% over the past one year. While a 52-week high of $5.51 was reached on 10/15/25, a 52-week low of $1.05 was recorded on 04/09/25.
Levels Of Support And Resistance For TSHA Stock
The 24-hour chart illustrates a support level at 4.86, which if violated will result in even more drops to 4.73. On the upside, there is a resistance level at 5.10. A further resistance level may holdings at 5.21.
How much short interest is there in Taysha Gene Therapies Inc?
A steep rise in short interest was recorded in Taysha Gene Therapies Inc stocks on 2025-10-15, dropping by -1.38 million shares to a total of 41.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 43.36 million shares. There was a decline of -3.29%, which implies that there is a negative sentiment for the stock.
